Tumor Biology

, Volume 35, Issue 7, pp 6343–6350 | Cite as

Diagnostic accuracy of contrast-enhanced ultrasound for renal cell carcinoma: a meta-analysis

  • Cong Wang
  • Chong Yu
  • Fang Yang
  • Guang Yang
Research Article


This meta-analysis aimed to identify the accuracy of contrast-enhanced ultrasonography (CEUS) for the diagnosis of renal cell carcinoma (RCC). We searched PubMed, Web of Science, Google Scholar, Cochrane Library, CISCOM, CINAHL, EBSCO, and CBM databases from inception through August 1, 2013 without language restrictions. Meta-analysis was conducted using STATA version 12.0 and Meta-Disc version 1.4 softwares. We calculated the summary statistics for sensitivity (Sen), specificity (Spe), positive and negative likelihood ratio (LR+/LR), diagnostic odds ratio (DOR), and receiver operating characteristic (SROC) curve. Eleven studies that met all inclusion criteria were included in this meta-analysis. A total of 567 RCC patients and 313 patients with benign renal tumors were assessed. All renal lesions were histologically confirmed after CEUS. The pooled Sen was 0.88 (95 %CI = 0.85 ∼ 0.90); the pooled Spe was 0.80 (95 %CI = 0.75 ∼ 0.85). The pooled LR+ was 4.30 (95 %CI = 2.65 ∼ 6.99); the pooled negative LR was 0.11 (95 %CI = 0.05 ∼ 0.22). The pooled DOR of CEUS in the diagnosis of RCC was 46.97 (95 % CI = 16.72 ∼ 131.97). The area under the SROC curve was 0.922 (standard error [SE] = 0.039). We found no evidence for publication bias (t = −1.00, P = 0.342). Our meta-analysis indicates that CEUS may have high diagnostic accuracy in differential diagnosis between benign and malignant renal tumors. Thus, CEUS may be a good tool for the diagnosis of RCC.


Contrast-enhanced ultrasonography Renal cell carcinoma Diagnostic accuracy Meta-analysis 



We would like to acknowledge the helpful comments on this paper received from our reviewers. Also, we would like to thank all our colleagues working in the first Department of Ultrasound, The First Affiliated Hospital to Dalian Medical University.

Conflicts of interest



  1. 1.
    Vegso G, Toronyi E, Hajdu M, Piros L, Gorog D, Deak PA, et al. Renal cell carcinoma of the native kidney: a frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis. Transplant Proc. 2011;43(4):1261–3.CrossRefPubMedGoogle Scholar
  2. 2.
    Jiang J, Chen Y, Zhou Y, Zhang H. Clear cell renal cell carcinoma: contrast-enhanced ultrasound features relation to tumor size. Eur J Radiol. 2010;73(1):162–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Linehan WM, Bratslavsky G, Pinto PA, Schmidt LS, Neckers L, Bottaro DP, et al. Molecular diagnosis and therapy of kidney cancer. Annu Rev Med. 2010;61:329–43.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Escudier B, Kataja V. Renal cell carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20 Suppl 4:81–2.PubMedGoogle Scholar
  5. 5.
    Tranquart F, Correas JM, Martegani A, Greppi B, Bokor D. Feasability of real time contrast enhanced ultrasound in renal disease. J Radiol. 2004;85(1):31–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Wang Z, Tang J, An L, Wang W, Luo Y, Li J, et al. Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma. J Ultrasound Med. 2007;26(6):757–62.PubMedGoogle Scholar
  7. 7.
    Jakobsen JA, Oyen R, Thomsen HS, Morcos SK. Safety of ultrasound contrast agents. Eur Radiol. 2005;15(5):941–5.CrossRefPubMedGoogle Scholar
  8. 8.
    McArthur C, Baxter GM. Current and potential renal applications of contrast-enhanced ultrasound. Clin Radiol. 2012;67(9):909–22.CrossRefPubMedGoogle Scholar
  9. 9.
    Zhou X, Yan F, Luo Y, Peng YL, Parajuly SS, Wen XR, et al. Characterization and diagnostic confidence of contrast-enhanced ultrasound for solid renal tumors. Ultrasound Med Biol. 2011;37(6):845–53.CrossRefPubMedGoogle Scholar
  10. 10.
    Xu ZF, Xu HX, Xie XY, Liu GJ, et al. Renal cell carcinoma: Real-time contrast-enhanced ultrasound findings. Abdom Imaging. 2010;35(6):750–6.Google Scholar
  11. 11.
    Drucker BJ. Renal cell carcinoma: current status and future prospects. Cancer Treat Rev. 2005;31(7):536–45.CrossRefPubMedGoogle Scholar
  12. 12.
    Sanchez K, Barr RG. Contrast-enhanced ultrasound detection and treatment guidance in a renal transplant patient with renal cell carcinoma. Ultrasound Quarterly. 2009;25(4):171–3.CrossRefPubMedGoogle Scholar
  13. 13.
    Xu ZF, Xu HX, Xie XY, Liu GJ, Zheng YL, Lu MD. Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography. J Ultrasound Med. 2010;29(5):709–17.PubMedGoogle Scholar
  14. 14.
    Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of quadas, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol. 2006;6:9.PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Hamza TH, Arends LR, van Houwelingen HC, Stijnen T. Multivariate random effects meta-analysis of diagnostic tests with multiple thresholds. BMC Med Res Methodol. 2009;9:73.PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Zintzaras E, Ioannidis JP. Hegesma: genome search meta-analysis and heterogeneity testing. Bioinformatics. 2005;21(18):3672–3.CrossRefPubMedGoogle Scholar
  17. 17.
    Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295(6):676–80.CrossRefPubMedGoogle Scholar
  18. 18.
    Wang F, Dai YP, Wan GS, Liang YY, Deng CH, Guo Y. A comparison study of contrast-enhanced ultrasonography and contrast-enhanced computed-tomography in the diagnosis of renal cell carcinoma. J Clin Urol. 2008;23(1):18–21.Google Scholar
  19. 19.
    Fan L, Lianfang D, Jinfang X, Yijin S, Ying W. Diagnostic efficacy of contrast-enhanced ultrasonography in solid renal parenchymal lesions with maximum diameters of 5 cm. J Ultrasound Med. 2008;27(6):875–85.PubMedGoogle Scholar
  20. 20.
    Liu J, Yang SX, Chen WW, Wang LL. The clinical value of ultrasonic contrast in the diagnosis of small renal carcinoma. J Clin Urol. 2008;23(7):499–501.Google Scholar
  21. 21.
    Wang Y, Jiang Y, Zhao YX, Yao GL, Zhang JP, Kang HL, et al. Value of contrast-enhanced ultrasonography in the diagnosis and differential diagnosis of renal tumors. Shanghai Med Imaging. 2009;18(4):285–7.Google Scholar
  22. 22.
    Ignee A, Straub B, Brix D, Schuessler G, Ott M, Dietrich CF. The value of contrast enhanced ultrasound (CEUS) in the characterisation of patients with renal masses. Clin Hemorheol Microcirc. 2010;46(4):275–90.PubMedGoogle Scholar
  23. 23.
    Xu ZF, Xie XY, Xu HX, Chen JX, Liu GJ, Lv MD. Comparison study of contrast-enhanced ultrasound and contrast ct on diagnosis of renal cell carcinoma. Chin J Urol. 2010;31(7):452–5.Google Scholar
  24. 24.
    Chen SH, Yang B, Lu GM. A comparison analysis of contrast-enhanced ultrasonography and contrast-enhanced computed-tomography in the diagnosis of renal lesions. J Med Imaging. 2011;21(9):1382–5.Google Scholar
  25. 25.
    Wang XH, Wang YJ, Lei CG. Evaluating the perfusion of occupying lesions of kidney and bladder with contrast-enhanced ultrasound. Clin Imaging. 2011;35(6):447–51.CrossRefPubMedGoogle Scholar
  26. 26.
    Yuan XC, Wang Y, Zhou AY, Chen L, Den LY, Liu J. Comparison on contrast-enhanced ultrasonography and ct in diagnosing renal cell carcinoma. Chin J Med Imaging Technol. 2011;27(12):2502–5.Google Scholar
  27. 27.
    Lu Q, Wang W, Huang B, Li C. Minimal fat renal angiomyolipoma: the initial study with contrast-enhanced ultrasonography. Ultrasound Med Biol. 2012;38(11):1896–901.CrossRefPubMedGoogle Scholar
  28. 28.
    Cheng WR. Application value of ultrasonogaphy in the diagnosis and differential diagnosis for kidney tumors. Hebei Med. 2013;19(7):977–80.Google Scholar
  29. 29.
    Hooley RJ, Scoutt LM, Philpotts LE. Breast ultrasonography: state of the art. Radiology. 2013;268(3):642–59.CrossRefPubMedGoogle Scholar
  30. 30.
    Bora MK. Internal jugular phlebectasia: diagnosis by ultrasonography, doppler and contrast ct. J Clin Diagn Res. 2013;7(6):1194–6.PubMedCentralPubMedGoogle Scholar
  31. 31.
    Postema M, Gilja OH. Contrast-enhanced and targeted ultrasound. World J Gastroenterol. 2011;17(1):28–41.PubMedCentralCrossRefPubMedGoogle Scholar
  32. 32.
    Kim AY, Kim SH, Kim YJ, Lee IH. Contrast-enhanced power doppler sonography for the differentiation of cystic renal lesions: preliminary study. J Ultrasound Med. 1999;18(9):581–8.PubMedGoogle Scholar
  33. 33.
    Spira D, Neumeister H, Spira SM, Hetzel J, Spengler W, von Weyhern CH, et al. Assessment of tumor vascularity in lung cancer using volume perfusion ct (VPCT) with histopathologic comparison: a further step toward an individualized tumor characterization. J Comput Assist Tomogr. 2013;37(1):15–21.CrossRefPubMedGoogle Scholar
  34. 34.
    Xue LY, Lu Q, Huang BJ, Li CL, Yan CJ, Wen JX, et al. Evaluation of renal urothelial carcinoma by contrast-enhanced ultrasonography. Eur J Radiol. 2013;82(4):e151–7.CrossRefPubMedGoogle Scholar
  35. 35.
    Reichelt O, Wunderlich H, Weirich T, Schlichter A, Schubert J. Computerized contrast angiosonography: a new diagnostic tool for the urologist? BJU Int. 2001;88(1):9–14.CrossRefPubMedGoogle Scholar
  36. 36.
    Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A. 1990;87(24):9868–72.PubMedCentralCrossRefPubMedGoogle Scholar
  37. 37.
    Pugliese F, Mollet NR, Runza G, van Mieghem C, Meijboom WB, Malagutti P, et al. Diagnostic accuracy of non-invasive 64-slice ct coronary angiography in patients with stable angina pectoris. Eur Radiol. 2006;16(3):575–82.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  1. 1.The First Department of UltrasoundThe First Affiliated Hospital to Dalian Medical UniversityDalianChina

Personalised recommendations